Innovative Oncology Focus Netris Pharma is dedicated to developing first-in-class therapeutics targeting Netrin-1, a key player in tumor progression, positioning it strongly within the cutting-edge oncology treatment market.
Strategic Research Location Located within the Léon Bérard Cancer Center in Lyon, France, the company benefits from close collaboration with top-tier cancer research institutions, enabling rapid translation of research findings into clinical solutions.
Funding and Development With over €8 million in recent funding and active development programs in cancer and endometriosis, Netris Pharma presents ample opportunities for partners interested in innovative therapeutic molecule development.
Recent Collaborations and Recognition Recent awards and participation in major conferences like ESMO indicate growing industry recognition, opening avenues for collaborative research, clinical trials, and co-marketing opportunities.
Growing Clinical Pipeline With expanding clinical trials and new leadership hires such as a Chief Medical Officer, Netris Pharma is poised for accelerated growth, offering partnership possibilities in clinical development and commercialization.
$100M$250M
$250M$500M
$50M$100M
$10B
$1B$10B
$50M$100M
$250M$500M
$250M$500MNETRIS Pharma uses 8 technology products and services including WordPress, Shopify, Twemoji, and more. Explore NETRIS Pharma's tech stack below.
| NETRIS Pharma Email Formats | Percentage |
| FirstLast@netrispharma.com | 46% |
| First.Last@netrispharma.com | 4% |
| FirstMiddleLast@netrispharma.com | 4% |
| FirstLast@netrispharma.com | 46% |
Pharmaceutical ManufacturingAuvergne-rhône-alpes, France11-50 Employees
Our collaborators and partners are driven by a desire to contribute to the development of new ways of fighting cancer. The therapies developed by NETRIS Pharma are based on cellular mechanisms identified by a world-renowned research group. Located in Léon Bérard Cancer Center (Lyon, France), NETRIS Pharma is a unique model of a biotechnology company integrated within a comprehensive cancer center.
Company Overview
Media & News
Funding & FinancialsNETRIS Pharma has raised a total of $8.2M of funding over 4 rounds. Their latest funding round was raised on Dec 19, 2023 in the amount of $8.2M.
NETRIS Pharma's revenue is estimated to be in the range of $1M$10M
Funding & FinancialsNETRIS Pharma has raised a total of $8.2M of funding over 4 rounds. Their latest funding round was raised on Dec 19, 2023 in the amount of $8.2M.
NETRIS Pharma's revenue is estimated to be in the range of $1M$10M
1-888-653-2347 
support@leadiq.com